Anna Mathews puff piece on Bart Stupak paints him as a sometimes overzealous crusader seeking to right wrongs at an out of control FDA...Good thing she didn't include this stirring Stupak statement -- from an LA Times article -- about why Andy von Eschenbach, Sandy Kweder, Janet Woodcock and the FDA's cafeteria guy should resign...
"The drug companies know that this administration ... will do nothing to them. There is no fear of the FDA. With this culture with laissez faire oversight and regulation, I think they should be gone. If we get rid of them, it will put the drug companies on notice."
Is there such a thing as laissez faire regulation?
Last time I checked, drug approvals were at an all-time low and the percentage of IND getting through the FDA had gone from 11 percent to 8 percent over a ten year period. The percent of drugs withdrawn has remained the same over that same time period. Laissez faire?
Oh and has anyone given one tenth of the coverage to the fact that the NIH pulled the plug on the ACCORD study that killed people compared to the ENHANCE trial that did not? In both cases the protocols were changed midstream and ACCORD even had a data safety monitoring board.
I don't see Stupak holding a hearing on that. Maybe it's not a case of laissez faire regulation. Or maybe it's just that you get less media coverage.
http://online.wsj.com/article/SB120347636748679131.html?mod=home_health_right
"The drug companies know that this administration ... will do nothing to them. There is no fear of the FDA. With this culture with laissez faire oversight and regulation, I think they should be gone. If we get rid of them, it will put the drug companies on notice."
Is there such a thing as laissez faire regulation?
Last time I checked, drug approvals were at an all-time low and the percentage of IND getting through the FDA had gone from 11 percent to 8 percent over a ten year period. The percent of drugs withdrawn has remained the same over that same time period. Laissez faire?
Oh and has anyone given one tenth of the coverage to the fact that the NIH pulled the plug on the ACCORD study that killed people compared to the ENHANCE trial that did not? In both cases the protocols were changed midstream and ACCORD even had a data safety monitoring board.
I don't see Stupak holding a hearing on that. Maybe it's not a case of laissez faire regulation. Or maybe it's just that you get less media coverage.
http://online.wsj.com/article/SB120347636748679131.html?mod=home_health_right
